176 related articles for article (PubMed ID: 19129744)
1. Racial/ethnic differences in the birth prevalence of spina bifida - United States, 1995-2005.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Jan; 57(53):1409-13. PubMed ID: 19129744
[TBL] [Abstract][Full Text] [Related]
2. Decline in the prevalence of spina bifida and anencephaly by race/ethnicity: 1995-2002.
Williams LJ; Rasmussen SA; Flores A; Kirby RS; Edmonds LD
Pediatrics; 2005 Sep; 116(3):580-6. PubMed ID: 16140696
[TBL] [Abstract][Full Text] [Related]
3. Trends in the postfortification prevalence of spina bifida and anencephaly in the United States.
Boulet SL; Yang Q; Mai C; Kirby RS; Collins JS; Robbins JM; Meyer R; Canfield MA; Mulinare J;
Birth Defects Res A Clin Mol Teratol; 2008 Jul; 82(7):527-32. PubMed ID: 18481813
[TBL] [Abstract][Full Text] [Related]
4. Updated estimates of neural tube defects prevented by mandatory folic Acid fortification - United States, 1995-2011.
Williams J; Mai CT; Mulinare J; Isenburg J; Flood TJ; Ethen M; Frohnert B; Kirby RS;
MMWR Morb Mortal Wkly Rep; 2015 Jan; 64(1):1-5. PubMed ID: 25590678
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of spina bifida at birth--United States, 1983-1990: a comparison of two surveillance systems.
Lary JM; Edmonds LD
MMWR CDC Surveill Summ; 1996 Apr; 45(2):15-26. PubMed ID: 8602137
[TBL] [Abstract][Full Text] [Related]
6. Estimate of the potential impact of folic acid fortification of corn masa flour on the prevention of neural tube defects.
Tinker SC; Devine O; Mai C; Hamner HC; Reefhuis J; Gilboa SM; Dowling NF; Honein MA
Birth Defects Res A Clin Mol Teratol; 2013 Oct; 97(10):649-57. PubMed ID: 24142499
[TBL] [Abstract][Full Text] [Related]
7. Spina bifida and anencephaly before and after folic acid mandate--United States, 1995-1996 and 1999-2000.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2004 May; 53(17):362-5. PubMed ID: 15129193
[TBL] [Abstract][Full Text] [Related]
8. Surveillance for anencephaly and spina bifida and the impact of prenatal diagnosis--United States, 1985-1994.
Cragan JD; Roberts HE; Edmonds LD; Khoury MJ; Kirby RS; Shaw GM; Velie EM; Merz RD; Forrester MB; Williamson RA; Krishnamurti DS; Stevenson RE; Dean JH
MMWR CDC Surveill Summ; 1995 Aug; 44(4):1-13. PubMed ID: 7637675
[TBL] [Abstract][Full Text] [Related]
9. Global Birth Prevalence of Spina Bifida by Folic Acid Fortification Status: A Systematic Review and Meta-Analysis.
Atta CA; Fiest KM; Frolkis AD; Jette N; Pringsheim T; St Germaine-Smith C; Rajapakse T; Kaplan GG; Metcalfe A
Am J Public Health; 2016 Jan; 106(1):e24-34. PubMed ID: 26562127
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States.
Williams LJ; Mai CT; Edmonds LD; Shaw GM; Kirby RS; Hobbs CA; Sever LE; Miller LA; Meaney FJ; Levitt M
Teratology; 2002 Jul; 66(1):33-9. PubMed ID: 12115778
[TBL] [Abstract][Full Text] [Related]
11. Changes in Spina Bifida Lesion Level after Folic Acid Fortification in the US.
Mai CT; Evans J; Alverson CJ; Yue X; Flood T; Arnold K; Nestoridi E; Denson L; Adisa O; Moore CA; Nance A; Zielke K; Rice S; Shan X; Dean JH; Ethen M; Hansen B; Isenburg J; Kirby RS
J Pediatr; 2022 Oct; 249():59-66.e1. PubMed ID: 35772508
[TBL] [Abstract][Full Text] [Related]
12. Spina bifida and anencephaly prevalence--United States, 1991-2001.
Mathews TJ; Honein MA; Erickson JD
MMWR Recomm Rep; 2002 Sep; 51(RR-13):9-11. PubMed ID: 12353510
[TBL] [Abstract][Full Text] [Related]
13. Spina bifida subtypes and sub-phenotypes by maternal race/ethnicity in the National Birth Defects Prevention Study.
Agopian AJ; Canfield MA; Olney RS; Lupo PJ; Ramadhani T; Mitchell LE; Shaw GM; Moore CA;
Am J Med Genet A; 2012 Jan; 158A(1):109-15. PubMed ID: 22140002
[TBL] [Abstract][Full Text] [Related]
14. Survival of infants with neural tube defects in the presence of folic acid fortification.
Bol KA; Collins JS; Kirby RS;
Pediatrics; 2006 Mar; 117(3):803-13. PubMed ID: 16510661
[TBL] [Abstract][Full Text] [Related]
15. Supplement use and other characteristics among pregnant women with a previous pregnancy affected by a neural tube defect - United States, 1997-2009.
Arth A; Tinker S; Moore C; Canfield M; Agopian A; Reefhuis J;
MMWR Morb Mortal Wkly Rep; 2015 Jan; 64(1):6-9. PubMed ID: 25590679
[TBL] [Abstract][Full Text] [Related]
16. Preventable spina bifida and anencephaly in Europe.
Obeid R; Pietrzik K; Oakley GP; Kancherla V; Holzgreve W; Wieser S
Birth Defects Res A Clin Mol Teratol; 2015 Sep; 103(9):763-71. PubMed ID: 26178749
[TBL] [Abstract][Full Text] [Related]
17. CDC Grand Rounds: additional opportunities to prevent neural tube defects with folic acid fortification.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2010 Aug; 59(31):980-4. PubMed ID: 20703205
[TBL] [Abstract][Full Text] [Related]
18. Folic acid intake and spina bifida in the era of dietary folic acid fortification.
Ahrens K; Yazdy MM; Mitchell AA; Werler MM
Epidemiology; 2011 Sep; 22(5):731-7. PubMed ID: 21659881
[TBL] [Abstract][Full Text] [Related]
19. Hispanic origin and neural tube defects in Houston/Harris County, Texas. I. Descriptive epidemiology.
Canfield MA; Annegers JF; Brender JD; Cooper SP; Greenberg F
Am J Epidemiol; 1996 Jan; 143(1):1-11. PubMed ID: 8533740
[TBL] [Abstract][Full Text] [Related]
20. Birth defects in Arkansas: is folic acid fortification making a difference?
Simmons CJ; Mosley BS; Fulton-Bond CA; Hobbs CA
Birth Defects Res A Clin Mol Teratol; 2004 Sep; 70(9):559-64. PubMed ID: 15368553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
